State Of Wisconsin Investment Board Alaunos Therapeutics, Inc. Transaction History

State Of Wisconsin Investment Board

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$1.09 - $1.89 $312,721 - $542,241	-286,900 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$2.82 - $5.6 $48,504 - $96,320	-17,200 Reduced 5.66%	286,900 $1.03 Million
Q4 2020 Feb 03, 2021	SELL	$2.09 - $3.09 $79,002 - $116,802	-37,800 Reduced 11.06%	304,100 $766,000
Q3 2020 Nov 16, 2020	BUY	$2.39 - $3.43 $199,087 - $285,719	83,300 Added 32.21%	341,900 $862,000
Q2 2020 Aug 12, 2020	BUY	$2.2 - $3.71 $23,760 - $40,068	10,800 Added 4.36%	258,600 $848,000
Q1 2020 May 06, 2020	BUY	$1.9 - $4.98 $13,300 - $34,860	7,000 Added 2.91%	247,800 $607,000
Q3 2019 Nov 12, 2019	BUY	$4.13 - $6.94 $246,974 - $415,012	59,800 Added 33.04%	240,800 $1.03 Million
Q2 2019 Aug 14, 2019	BUY	$3.98 - $6.2 $15,920 - $24,800	4,000 Added 2.26%	181,000 $1.06 Million
Q1 2019 May 13, 2019	BUY	$2.0 - $4.4 $81,200 - $178,640	40,600 Added 29.77%	177,000 $681,000
Q4 2018 Feb 11, 2019	BUY	$1.61 - $3.62 $58,604 - $131,768	36,400 Added 36.4%	136,400 $255,000
Q3 2017 Nov 01, 2017	BUY	$4.99 - $6.57 $499,000 - $657,000	100,000	100,000 $614,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $383M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.